Pleasantly surprised? If this raises enough to cover until FDA approval and the HIV indication isn't sold, then yes I will be pleasantly surprised.
If we keep HIV then we make enough for cancer trials. If sold and we receive a fraction of the sales then further fundraising will occur.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-